PACB News and Press, Pacific Biosciences of California Inc. From 10/22/25

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 pm Eastern Time. The call will be webcast and may be accessed...

MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms designed to lower sequencing costs, add new multiomic capabilities, and expand support for regul...

MENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its HiFi sequencing technology has been selected as the primary platform for the Korean Pangenome Refe...

MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate compr...

MENLO PARK, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions. Under the new agr...

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier screening market with a significantly expanded and enhanced suite of P...

2025-09-10 14:45:11 ET Pacific Biosciences of California, Inc. (PACB) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT... Read the full article on Seeking Alpha For further details see: Pacific Biosciences Of California, Inc. (PACB) Pre...

MENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined the PacBio Compatible program. The partnership brings EpiCy...

2025-08-08 20:18:44 ET Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Conference Call August 07, 2025, 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R. Gibson - Chief Financial Officer Todd Friedman - Co...

2025-08-07 16:09:24 ET More on Pacific Biosciences of California Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer Pacific Biosciences of California: Sell Before Potential Reverse Split Pacific Biosciences: A Mountain Of Red Flags ...